Abstract 1649: Development of a near-infrared daratumumab-based contrast agent for preclinical imaging of CD38 expression in multiple myeloma
Authors: Nicholas Cho, Sooah Ko, Monica Shokeen
Published: 2020-09-04
DOI:
10.1158/1538-7445.am2020-1649
Source:
Full article
Abstract
Abstract